
Stratified News from Protagen
Here you will find our quarterly newsletter, “Stratified News from Dortmund”. With our newsletter we intend to regularly update you on developments at Protagen in a fresh and colorful format and we hope that you like it. The newsletter is one way of interacting with you, our friends and collaborators, and we strive to improve our communication on an ongoing basis.

2018
April 2018 (PDF)
January 2018 (PDF)
2017
October 2017 (PDF)
July 2017 (PDF)
April 2017 (PDF)
January 2017 (PDF)
2016
October 2016 (PDF)
July 2016 (PDF)
April 2016 (PDF)
January 2016 (PDF)
2015
October 2015 (PDF)
July 2015 (PDF)
April 2015 (PDF)
January 2015 (PDF)
2014
October 2014 (PDF)
July 2014 (PDF)
Protagen’s corporate leadership team combines over 40 years of commercial expertise and experience within the biotechnology industry, with a background spanning immunology, oncology, biomarker discovery and more.
Protagen is currently setting up an international scientific advisory board with key opinion leaders from the immuno-oncology and autoimmune disease fields. These expert panels will support our efforts in engaging with the medical and scientific community to develop products that are aimed at market needs.
Protagen has a number of established and committed investors, but is always looking at entering into new partnerships to help progress its research and commercialization efforts. If you are interested in investing in the company, please contact us.
Protagen is always looking to expand its talented and experienced team. For information on some of the job roles available, see below.
Protagen is dedicated to the development of powerful diagnostic tools that aid successful therapeutic development and facilitate improved treatment strategies in the areas of autoimmune disease and immuno-oncology.

Get in touch
Improving the treatment of cancer and autoimmune disease is our passion, and we always welcome the chance to discuss these topics with current and prospective customers, patients and clinicians alike.

Copyright © 1997-2018
Protagen AG, Dortmund, Germany